参考文献/References:
[1] Tomer Y. Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics[J]. Annu Rev Pathol,2014,9:147-156. DOI: 10.1146/annurev-pathol-012513-104713.
[2] 张怡, 袁卫红. 硒与自身免疫性甲状腺疾病[J]. 国际放射医学核医学杂志, 2012, 36(6):376-379. DOI: 10.3760/cma.j.issn.1673-4114.2012.06.013.
[3] Duntas LH. Selenium and the thyroid: a close-knit connection[J].J Clin Endocrinol Metab,2010,95(12):5180-5188. DOI: 10.1210/jc.2010-0191.
[4] 金晶, 胡耀敏, 刘伟. 硒治疗自身免疫性甲状腺炎的系统评价[J]. 上海交通大学学报(医学版), 2010, 30(11):1356-1360. DOI: 10.3969/j.issn.1674-8115.2010.11.009.
[5] Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary[J]. Control Clin Trials, 1996,17(1):1-12.
[6] 朱平, 周冬梅, 李伟. 硒制剂治疗桥本甲状腺炎伴甲减患者30例临床疗效[J]. 中国老年学杂志, 2012, 32(8):1710-1711. DOI: 10.3969/j.issn.1005-9202.2012. 08.082.
[7] Gärtner R, Gasnier BC, Dietrich JW,et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations[J]. J Clin Endocrinol Metab,2002,87(4):1687-1691.
[8] Duntas LH, Mantzou E, Koutras DA. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis[J].Eur J Endocrinol,2003,148(4):389-393.
[9] Gärtner R, Gasnier BC. Selenium in the treatment of autoimmune thyroiditis[J].Biofactors,2003,19(3-4):165-170.
[10] 王栋钢, 雷培芸, 杨咏梅, 等. 硒对儿童桥本甲状腺炎的影响[J]. 广东微量元素科学, 2004, 11(2):34-36.
[11] Turker O, Kumanlioglu K, Karapolat I,et al. Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses[J].J Endocrinol,2006,190(1):151-156.
[12] Karanikas G, Schuetz M, Kontur S, et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis[J].Thyroid,2008,18(1):7-12. DOI: 10.1089/thy.2007.0127.
[13] 颜美珠, 王曙, 缪婕, 等. 硒在桥本甲状腺炎中的作用[J]. 中华内分泌代谢杂志, 2008, 24(2):194-195. DOI:10.3321/J.ISSN.1000-6699.2008.02.026.
[14] Bonfig W, Gärtner R, Schmidt H. Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis[J].SciWorld J,2010,10:990-996. DOI: 10.1100/tsw.2010.91.
[15] Nacamulli D, Mian C, Petricca D, et al. Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis[J].Clin Endocrinol(Oxf),2010,73(4):535-539. DOI: 10.1111/j.1365-2265.2009.03758.x.
[16] 张洁红, 张彤, 段敏虹, 等. 硒对成人桥本甲状腺炎的影响[J]. 中国实用医刊, 2010, 37(9):40-41. DOI: 10.376/cma.j.issn.1674- 4756.2010.09.018.
[17] Krysiak R, Okopien B. The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis[J].J Clin Endocrinol Metab,2011,96(7):2206-2215.DOI: 10.1210/jc.2010-2986.
[18] 雷水红, 蔡霞, 李经, 等. 硒联合抑亢丸、甲巯咪唑治疗桥本甲状腺炎性甲亢的疗效观察[J]. 山东医药, 2011, 51(37):88-89.
[19] Anastasilakis AD, Toulis KA, Nisianakis P,et al. Selenomethionine treatment in patients with autoimmune thyroiditis: a prospective, quasi-randomised trial[J].Int J Clin Pract,2012,66(4):378-383. DOI: 10.1111/j.1742-1241.2011.02879.x.
[20] Bhuyan AK, Sarma D, Saikia UK. Selenium and the thyroid: a close-knit connection[J].Indian J Endocrinol Metab,2012,16(Suppl 2):S354-S355. DOI: 10.4103/2230-8210.104090.
[21] Krysiak R, Okopien B. Haemostatic effects of levothyroxine and selenomethionine in euthyroid patients with Hashimoto's thyroiditis[J].Thromb Haemost,2012,108(5):973-980. DOI: 10.1160/TH12-04-0275.
[22] 薛冀苏, 幸思忠. 补硒治疗对桥本氏甲状腺炎的临床观察研究[J]. 当代医学, 2012, 18(12):90-91. DOI: 10.3969/j.issn.1009-4393.2012.12.062.
[23] 朱琳, 白雪, 腾卫平, 等. 硒对自身免疫性甲状腺炎自身抗体的影响[J]. 中华医学杂志, 2012, 92(32):2256-2260. DOI: 10.3760/cma.j.issn.0376-2491.2012.32.008.
[24] 邓顺有, 陈小燕, 吴琳英, 等. 硒对甲状腺功能正常的桥本甲状腺炎的影响研究[J]. 中国全科医学, 2013, 16(7C):2483-2485. DOI: 10.3969/j. issn.1007-9572.2013.07.089.
[25] 吕飞娟, 杨燕玲, 许景生, 等. 亚硒酸钠治疗桥本甲状腺炎的临床观察[J]. 临床军医杂志, 2013, 41(1):35-41.DOI:10.3969/j.issn.1671-3826.2013.01.018.
[26] 张薇, 王俊芳, 李京丽, 等. 硒对桥本甲状腺炎患者TPOAb及TGAb水平的影响[J]. 中国医学创新, 2013, 10(14):13-14. DOI: 10.3969/j.issn.1674-4985.2013.14.007.
[27] Eskes SA, Endert E, Fliers E,et al. Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies[J]. Clin Endocrinol(Oxf),2014,80(3):444-451. DOI: 10.1111/cen.12284.
[28] 姜云生. 硒酵母治疗桥本病100例分析[J]. 吉林医学, 2014, 35(11):2303-2304.
[29] 曾秀琴, 马卫英. 硒酵母降低桥本甲状腺炎相关抗体滴度的疗效观察[J]. 实用糖尿病杂志, 2014, 10(2):57-58.
[30] Claudio M, George JK, Gerasimos EK, et al. Selenium and the course of mild Graves' orbitopathy[J]. N Engl Med, 2011, 364(20):1921-1931.DOI:10.1056/NEJMoa1012985.
[31] 杜映红, 毛睿睿. 硒联合甲巯咪唑治疗Graves'病患者的临床研究[J]. 湖南中医药大学学报, 2013, 33(12):73-108. DOI: 10.3969/j.issn.1674-070X.2013.12.042.073.01.
[32] 王俊芳, 张薇, 李京丽, 等. 硒对Graves'病患者血清TPOAb、TGAb水平的影响[J]. 中西医结合心脑血管病杂志, 2013, 11(4):502-503.DOI:10.3969/j.issn.1672-1349.2013.04.062.
[33] 朱翠颜, 王筱菁, 邓承宗. 硒对弥漫性毒性甲状腺肿自身免疫抗体的影响[J]. 吉林医学, 2013, 34(16):3147-3148.DOI:10.3969/j.issn.1004-0412.2013.16.039.
[34] 黄珊, 谢珊, 冼碧霞. 微量元素硒对弥漫性甲状腺肿的影响及其护理探讨[J]. 海南医学, 2014, 25(10):1546-1547. DOI: 10.3969/j.issn.1003-6350.2014.10.0601.
[35] 赖景雄. 硒酵母片联合甲巯咪唑治疗Graves'病疗效观察[J]. 药物流行病学杂志, 2014, 23(8):472-474.
[36] Toulis KA, Anastasilakis AD, Tzellos TG,et al. Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis[J].Thyroid,2010,20(10):1163-1173. DOI:10.1089/thy.2009.0351.
[37] van Zuuren EJ, Albusta AY, Fedorowicz Z, et al. Selenium supplementation for Hashimoto's thyroiditis[J].Cochrane Database Syst Rev,2013,6:CD010223. DOI: 10.1002/14651858.CD010223.pub2.
相似文献/References:
[1]朱丹,陈国芳,刘超,等.糖尿病患者合并甲状腺功能异常的机制
及其影响[J].国际内分泌代谢杂志,2016,36(03):206.[doi:10.3760/cma.j.issn.1673-4157.2016.03.16]
Zhu Dan*,Chen Guofang,Liu Chao,et al.Mechanisms of diabetes combined with thyroid dysfunction and its influence[J].International Journal of Endocrinology and Metabolism,2016,36(04):206.[doi:10.3760/cma.j.issn.1673-4157.2016.03.16]
[2]郑慧娟,魏璠,魏军平.自噬与自身免疫性甲状腺疾病[J].国际内分泌代谢杂志,2017,37(01):17.[doi:10.3760/cma.j.issn.1673-4157.2017.01.05]
Zheng Huijuan,Wei Fan,Wei Junping..Autophagy and autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2017,37(04):17.[doi:10.3760/cma.j.issn.1673-4157.2017.01.05]
[3]司马盼盼 孙良阁.多囊卵巢综合征与自身免疫性甲状腺疾病的相关性[J].国际内分泌代谢杂志,2018,38(03):163.[doi:10.3760/cma.j.issn.1673-4157.2018.03.005]
Sima Panpan,Sun Liangge..Correlation between polycystic ovary syndrome and autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2018,38(04):163.[doi:10.3760/cma.j.issn.1673-4157.2018.03.005]
[4]相萍萍 刘超.滤泡辅助性T细胞、滤泡调节性T细胞与自身免疫性
甲状腺疾病[J].国际内分泌代谢杂志,2019,39(03):168.[doi:10.3760/cma.j.issn.1673-4157.2019.03.006]
Xiang Pingping,Liu Chao.T foliicular helper cells, T follicular regulatory cells and autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2019,39(04):168.[doi:10.3760/cma.j.issn.1673-4157.2019.03.006]
[5]杨小颖 唐露霖 尚文斌.表观遗传修饰在自身免疫性甲状腺疾病发病中的作用[J].国际内分泌代谢杂志,2020,40(03):169.[doi:10.3760/cma.j.issn.1673-4157.2020.03.006]
Yang Xiao-ying,Tang Lulin,Shang Wenbin.The role of epigenetic modification in the pathogenesis of autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2020,40(04):169.[doi:10.3760/cma.j.issn.1673-4157.2020.03.006]
[6]梁杏燕,赵捷,马红霞.自身免疫性甲状腺疾病对多囊卵巢综合征不良妊娠结局的影响[J].国际内分泌代谢杂志,2022,42(06):481.[doi:10.3760/cma.j.cn121383-20211016-10036]
Liang Xingyan,Zhao Jie,Ma Hongxia..Influence of autoimmune thyroid disease on adverse pregnant outcome in polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2022,42(04):481.[doi:10.3760/cma.j.cn121383-20211016-10036]